Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline.

Alzheimers Res Ther · 2023 · PMC9814201 · PMID 36604729

Europe PMC DOI

hedged sentence

0.0970

closest p · 1.9× alpha

0.0970

boldest claim

The sentences

did not reach statistical significanceP = .097so close (0.05 < p ≤ 0.1)

A trend for reduced hippocampal volume in Aβ42/Aβ40(+) participants was found, although the difference did not reach statistical significance ( P = .097) (Supplementary Fig. 3 B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.